DS
Di Stefano, Antonio
12 papers · 121 citations · 2021–2025
Publications
12
Citations
121
Years
5
Publications
| Title | Year | Type | Citations |
|---|---|---|---|
|
Synthesis and Characterization of Memantine-Loaded Niosomes for Enhanced Alzheimer's Disease Targeting
|
2025 | Article | 2 |
|
Targeting Alzheimer's disease with novel dual-function 3,5-diaryl-4,5-dihydro-1H-pyrazole-1-carbothioamide derivatives
|
2024 | Article | 1 |
|
Anticancer Potential of Novel Cinnamoyl Derivatives against U87MG and SHSY-5Y Cell Lines
|
2024 | Article | 2 |
|
Novel styryl-thiazole hybrids as potential anti-Alzheimer's agents
|
2023 | Article | 8 |
|
Toxicity of Glycyl-l-Prolyl-l-Glutamate Pseudotripeptides: Cytotoxic, Oxidative, Genotoxic, and Embryotoxic Perspectives
|
2022 | Article | 2 |
|
Boron Nitride Nanoparticles Loaded with a Boron-Based Hybrid as a Promising Drug Carrier System for Alzheimer's Disease Treatment
|
2022 | Article | 18 |
|
Ameliorative Effects by Hexagonal Boron Nitride Nanoparticles against Beta Amyloid Induced Neurotoxicity
|
2022 | Article | 12 |
|
Synthesis and Biological Evaluation of Novel Cinnamic Acid-Based Antimicrobials
|
2022 | Article | 29 |
|
Boron-based hybrids as novel scaffolds for the development of drugs with neuroprotective properties
|
2021 | Article | 15 |
|
Anticancer effects of novel NSAIDs derivatives on cultured human glioblastoma cells
|
2021 | Article | 9 |
|
Potential Anticancer Effect of Carvacrol Codrugs on Human Glioblastoma Cells
|
2021 | Article | 11 |
|
Glycyl-L-Prolyl-L-Glutamate Pseudotripeptides for Treatment of Alzheimer's Disease
|
2021 | Article | 12 |